Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany
NCT03375424
·
clinicaltrials.gov ↗
UNKNOWN
Status
2500
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Treatment
Interventions
BIOLOGICAL:
vedolizumab
Sponsor
Ced Service GmbH